SOLANA CO (HSDT) Fundamental Analysis & Valuation
NASDAQ:HSDT • US42328V8761
Current stock price
2.01 USD
-0.05 (-2.43%)
At close:
2.01 USD
0 (0%)
After Hours:
This HSDT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. HSDT Profitability Analysis
1.1 Basic Checks
- HSDT had negative earnings in the past year.
- In the past year HSDT has reported a negative cash flow from operations.
- HSDT had negative earnings in each of the past 5 years.
- In the past 5 years HSDT always reported negative operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of -77.82%, HSDT is doing worse than 75.13% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -77.82% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-175.99%
ROA(5y)-174.45%
ROE(3y)-552.67%
ROE(5y)-436.83%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- HSDT has a Gross Margin (49.63%) which is comparable to the rest of the industry.
- The Profit Margin and Operating Margin are not available for HSDT so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 49.63% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. HSDT Health Analysis
2.1 Basic Checks
- HSDT does not have a ROIC to compare to the WACC, probably because it is not profitable.
- HSDT has more shares outstanding than it did 1 year ago.
- HSDT has more shares outstanding than it did 5 years ago.
- HSDT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- Based on the Altman-Z score of -1.27, we must say that HSDT is in the distress zone and has some risk of bankruptcy.
- Looking at the Altman-Z score, with a value of -1.27, HSDT is in line with its industry, outperforming 40.21% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -1.27 |
ROIC/WACCN/A
WACC10.59%
2.3 Liquidity
- HSDT has a Current Ratio of 40.03. This indicates that HSDT is financially healthy and has no problem in meeting its short term obligations.
- HSDT has a better Current ratio (40.03) than 100.00% of its industry peers.
- HSDT has a Quick Ratio of 39.67. This indicates that HSDT is financially healthy and has no problem in meeting its short term obligations.
- HSDT's Quick ratio of 39.67 is amongst the best of the industry. HSDT outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 40.03 | ||
| Quick Ratio | 39.67 |
3. HSDT Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 73.97% over the past year.
- HSDT shows a strong growth in Revenue. In the last year, the Revenue has grown by 87.45%.
- HSDT shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -19.09% yearly.
EPS 1Y (TTM)73.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%102.81%
Revenue 1Y (TTM)87.45%
Revenue growth 3Y0%
Revenue growth 5Y-19.09%
Sales Q2Q%1266.67%
3.2 Future
- HSDT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 40.88% yearly.
- The Revenue is expected to grow by 177.16% on average over the next years. This is a very strong growth
EPS Next Y93.98%
EPS Next 2Y40.88%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-20.09%
Revenue Next 2Y18.3%
Revenue Next 3Y346.25%
Revenue Next 5Y177.16%
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. HSDT Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for HSDT. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HSDT. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- HSDT's earnings are expected to grow with 40.88% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.88%
EPS Next 3YN/A
5. HSDT Dividend Analysis
5.1 Amount
- No dividends for HSDT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
HSDT Fundamentals: All Metrics, Ratios and Statistics
2.01
-0.05 (-2.43%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-23 2026-03-23/amc
Earnings (Next)04-29 2026-04-29
Inst Owners20.55%
Inst Owner Change7.3%
Ins Owners0.02%
Ins Owner Change0%
Market Cap106.13M
Revenue(TTM)941.00K
Net Income(TTM)-370.37M
Analysts43.33
Price TargetN/A
Short Float %2.44%
Short Ratio2.3
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)89.81%
Min EPS beat(2)39.17%
Max EPS beat(2)140.46%
EPS beat(4)3
Avg EPS beat(4)46.76%
Min EPS beat(4)-6.38%
Max EPS beat(4)140.46%
EPS beat(8)6
Avg EPS beat(8)31.72%
EPS beat(12)9
Avg EPS beat(12)25.44%
EPS beat(16)12
Avg EPS beat(16)24.74%
Revenue beat(2)1
Avg Revenue beat(2)238.71%
Min Revenue beat(2)-43.79%
Max Revenue beat(2)521.21%
Revenue beat(4)2
Avg Revenue beat(4)118.62%
Min Revenue beat(4)-51.96%
Max Revenue beat(4)521.21%
Revenue beat(8)4
Avg Revenue beat(8)47.69%
Revenue beat(12)6
Avg Revenue beat(12)25.05%
Revenue beat(16)9
Avg Revenue beat(16)26.35%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 112.78 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-1206.39
EYN/A
EPS(NY)-65.79
Fwd EYN/A
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS0.02
BVpS-2.89
TBVpS-2.89
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -77.82% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 49.63% | ||
| FCFM | N/A |
ROA(3y)-175.99%
ROA(5y)-174.45%
ROE(3y)-552.67%
ROE(5y)-436.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 40.03 | ||
| Quick Ratio | 39.67 | ||
| Altman-Z | -1.27 |
F-Score5
WACC10.59%
ROIC/WACCN/A
Cap/Depr(3y)10.97%
Cap/Depr(5y)13.37%
Cap/Sales(3y)2.54%
Cap/Sales(5y)5.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)73.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%102.81%
EPS Next Y93.98%
EPS Next 2Y40.88%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)87.45%
Revenue growth 3Y0%
Revenue growth 5Y-19.09%
Sales Q2Q%1266.67%
Revenue Next Year-20.09%
Revenue Next 2Y18.3%
Revenue Next 3Y346.25%
Revenue Next 5Y177.16%
EBIT growth 1Y-18.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-5.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-6%
OCF growth 3YN/A
OCF growth 5YN/A
SOLANA CO / HSDT Fundamental Analysis FAQ
What is the fundamental rating for HSDT stock?
ChartMill assigns a fundamental rating of 2 / 10 to HSDT.
What is the valuation status of SOLANA CO (HSDT) stock?
ChartMill assigns a valuation rating of 1 / 10 to SOLANA CO (HSDT). This can be considered as Overvalued.
What is the profitability of HSDT stock?
SOLANA CO (HSDT) has a profitability rating of 0 / 10.
How financially healthy is SOLANA CO?
The financial health rating of SOLANA CO (HSDT) is 4 / 10.